Primary Site >> Liver Cancer

Gene >> PRC1

Journal: Clin Cancer Res. 2011 Sep 15;17(18):6040-51.
Title: Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma.
Author: Wang, Suk Mei|Ooi, London Lucien P J|Hui, Kam M
PMID: 21825042
Journal: Am J Cancer Res. 2015 Sep 15;5(10):2969-79. eCollection 2015.
Title: Genetic alteration and misexpression of Polycomb group genes in hepatocellular carcinoma.
Author: Gao, Shu-Bin|Sun, Shi-Long|Zheng, Qi-Lin|Zhang, Li|Zhu, Yuequan|Jin, Guang-Hui|Xue, Li-Xiang
PMID: 26693053
Journal: Gut. 2016 Sep;65(9):1522-34.
Title: The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/beta-catenin signalling pathway.
Author: Chen, Jianxiang|Rajasekaran, Muthukumar|Xia, Hongping|Zhang, Xiaoqian|Kong, Shik Nie|Sekar, Karthik|Seshachalam, Veerabrahma Pratap|Deivasigamani, Amudha|Goh, Brian Kim Poh|Ooi, London Lucien|Hong, Wanjin|Hui, Kam M
PMID: 26941395
Journal: J Cancer. 2017 Feb 25;8(5):801-808.
Title: Protein Regulator of Cytokinesis PRC1 Confers Chemoresistance and Predicts an Unfavorable Postoperative Survival of Hepatocellular Carcinoma Patients.
Author: Wang, Yu|Shi, Feng|Xing, Guo-Hui|Xie, Ping|Zhao, Na|Yin, Yu-Feng|Sun, Shu-Yan|He, Jing|Wang, Ying|Xuan, Shi-Ying
PMID: 28382142
Journal: Exp Biol Med (Maywood). 2017 Jun;242(11):1142-1149.
Title: Atypical regulators of Wnt/beta-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma.
Author: Chen, Jianxiang|Rajasekaran, Muthukumar|Hui, Kam M
PMID: 28429652
Journal: Mol Cancer. 2017 Jun 24;16(1):108.
Title: PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/beta-catenin signaling pathway.
Author: Zhan, Ping|Zhang, Bin|Xi, Guang-Min|Wu, Ying|Liu, Hong-Bing|Liu, Ya-Fang|Xu, Wu-Jian|Zhu, Qing-Qing|Cai, Feng|Zhou, Ze-Jun|Miu, Ying-Ying|Wang, Xiao-Xia|Jin, Jia-Jia|Li, Qian|Qian, Li-Ping|Lv, Tang-Feng|Song, Yong
PMID: 28646916
Journal: Biochem Biophys Res Commun. 2018 Jan 1;495(1):414-420.
Title: Chitosan-coated doxorubicin nano-particles drug delivery system inhibits cell growth of liver cancer via p53/PRC1 pathway.
Author: Ye, Bai-Liang|Zheng, Ru|Ruan, Xiao-Jiao|Zheng, Zhi-Hai|Cai, Hua-Jie
PMID: 29097204
Journal: Cancer Res. 2018 Jan 15;78(2):359-371.
Title: The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival.
Author: Shen, Jiajia|Li, Pengyu|Shao, Xuejing|Yang, Yang|Liu, Xiujun|Feng, Min|Yu, Qiang|Hu, Ronggui|Wang, Zhen
PMID: 29187402
Journal: Onco Targets Ther. 2018 Apr 4;11:1861-1869.
Title: Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis.
Author: Zhou, Lei|Du, Yanyan|Kong, Lingqun|Zhang, Xingyuan|Chen, Qiangpu
PMID: 29670361
Journal: Cell Death Dis. 2018 May 1;9(5):534.
Title: Reducing protein regulator of cytokinesis 1 as a prospective therapy for hepatocellular carcinoma.
Author: Liu, Xinran|Li, Yangkai|Meng, Lijing|Liu, Xin-Yuan|Peng, Anlin|Chen, Yuchen|Liu, Chengyu|Chen, Hong|Sun, Sheng|Miao, Xiaoping|Zhang, Yu|Zheng, Ling|Huang, Kun
PMID: 29748662
Journal: Gene. 2018 Aug 7. pii: S0378-1119(18)30872-2.
Title: BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
Author: Janaki Ramaiah, M|Vaishnave, S
PMID: 30096458
Journal: Mol Cells. 2018 Aug 27. pii: molcells.2018.0181.
Title: MicroRNA-766-3p Inhibits Tumour Progression by Targeting Wnt3a in Hepatocellular Carcinoma.
Author: You, Yu|Que, Keting|Zhou, Yun|Zhang, Zhen|Zhao, Xiaoping|Gong, Jianpin|Liu, Zuojin
PMID: 30145863